Company: PMVP
Filing Date: 2025-06-09
Form Type: 8-K
Source: 0001193125-25-137497
Chunk: 1

Company: PMV Pharmaceuticals, Inc.
Filing Date: 2025-06-09
Form: 8-K
Item: Item 5.07
Chunk 1
---
holders.

Proposal 3. Ratification of Independent Registered Public Accounting Firm

The Company’s stockholders ratified the selection by the Audit Committee of the Company’s Board of Directors of Ernst & Young LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2025. The final voting results are as follows:

         FOR      AGAINST      ABSTAIN  
 ────────────────────────────────────────
  39,963,653      638,940            0  

For more information about the foregoing proposals, see the Proxy Statement as filed with the SEC.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

  PMV PHARMACEUTICALS, INC.                               
  By:                            /s/ Michael Carulli      
                                 Michael Carulli          
                                 Chief Financial Officer  

Date: June 9, 2025